Precision Medicine in Oncology® | Specialty

The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating lymphocyte therapy, and other tailored treatments. This page features news articles, interviews in written and video format, and podcasts that focus on updates and ongoing research with personalized therapies across solid and hematologic tumors.

Immunotherapy in Liver Cancer

September 8th 2017

Ongoing Clinical Trials in Second-Line HCC

September 8th 2017

Second-Line HCC: Unmet Needs

September 8th 2017

HCC: Evolution of Frontline Treatment

September 8th 2017

Frontline Lenvatinib in HCC: Study 304

September 8th 2017

Unmet Needs in Systemic Therapy for Liver Cancer

September 8th 2017

Initial Treatment Decisions in Liver Cancer

September 8th 2017

Evidence With SIRT in HCC

September 8th 2017

Role of TACE in Liver Cancer

September 8th 2017

Radiofrequency Ablation Vs Resection in HCC

September 8th 2017

HCC and Liver Transplantation

September 8th 2017

Liver Cancer Screening Strategies

September 8th 2017

Comorbidities and Management of HCC

September 8th 2017

Importance of Multidisciplinary Care in Liver Cancer

September 8th 2017

Maintenance Rucaparib Highly Effective Across Ovarian Cancer Subtypes

September 8th 2017

Maintenance treatment with the PARP inhibitor rucaparib improved median progression-free survival by 11.2 months compared with placebo for patients with BRCA-mutant platinum-sensitive ovarian cancer.

Mendelsohn's Antibody Research Reverberates Today

August 31st 2017

John Mendelsohn, MD, served as president of The University of Texas MD Anderson Cancer Center for a 15-year period that saw that institution’s size triple and its budget quadruple.

Liquid Biopsy for NSCLC: Emerging Developments

August 29th 2017

Future Directions for Liquid Biopsy in NSCLC

August 29th 2017

Liquid Biopsy and Next-Generation Sequencing

August 29th 2017

Interpretation of NSCLC Plasma Genotyping Results

August 29th 2017